Trial Profile
Phase I Clinical Trial of Ixabepilone and Pemetrexed in Advanced Solid Tumors.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I
Latest Information Update: 05 Mar 2014
Price :
$35
*
At a glance
- Drugs Ixabepilone (Primary) ; Pemetrexed (Primary)
- Indications Advanced breast cancer; Cervical cancer; Lung cancer; Mesothelioma; Ovarian cancer; Prostate cancer; Solid tumours; Uterine cancer
- Focus Adverse reactions; Therapeutic Use
- 05 Aug 2010 New trial record